Ítem
Acceso Abierto

Eficacia del láser de Co2 en el tratamiento del liquen escleroso vulvar refractario

Mostrar el registro sencillo de la publicación
dc.contributor.advisorOspina Medina, María Cristina
dc.creatorCastillo Medina, Luis Felipe
dc.creatorRincón Bonilla, Johnnattan Francisco
dc.creator.degreeMagíster en Epidemiología
dc.creator.degreeLevelMaestría
dc.date.accessioned2025-09-11T16:26:29Z
dc.date.available2025-09-11T16:26:29Z
dc.date.created2025-05-26
dc.descriptionEl liquen escleroso vulvar (LEV) es una dermatosis inflamatoria crónica que afecta de forma predominante a la vulva. Ha sido descrito en todos los grupos etarios, pero tiene mayor prevalencia en mujeres postmenopáusicas. Se desconocen las causas por lo que se atribuye probablemente a una combinación de factores. En la actualidad se considera una enfermedad autoinmune en pacientes genéticamente predispuestos. El objetivo del estudio es revisar la literatura publicada relacionada con la eficacia de la aplicación del láser CO2 en el tratamiento del liquen escleroso vulvar refractario al tratamiento con corticoides tópicos.
dc.description.abstractVulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis that predominantly affects the vulva. It has been described across all age groups, but it is most prevalent in postmenopausal women. The exact cause remains unknown, although it is likely due to a combination of factors. Currently, it is considered an autoimmune disease in genetically predisposed individuals. The objective of this study is to review the existing literature regarding the efficacy of CO₂ laser therapy in the treatment of vulvar lichen sclerosus that is refractory to topical corticosteroid therapy.
dc.format.extent72 pp
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_46447
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/46447
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisherUniversidad CES. Facultad de Medicina
dc.publisher.departmentEscuela de Medicina y Ciencias de la Saludspa
dc.publisher.programMaestría en Epidemiologíaspa
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.source.bibliographicCitationPowell JJ, Wojnarowska F. Lichen sclerosus. The Lancet. 1999;353(9166):1777-83
dc.source.bibliographicCitationTasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol. 2003;28(2):128-33
dc.source.bibliographicCitationLansdorp CA, van den Hondel KE, Korfage IJ, van Gestel MJ, van der Meijden WI. Quality of life in Dutch women with lichen sclerosus. Br J Dermatol. 2013;168(4):787- 93
dc.source.bibliographicCitationFistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013;14(1):27-47.
dc.source.bibliographicCitationNeill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163(4):672-82.
dc.source.bibliographicCitationKreuter A, Kryvosheyeva Y, Terras S, Moritz R, Möllenhoff K, Altmeyer P, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93(2):238-41
dc.source.bibliographicCitationGünthert AR, Duclos K, Jahns BG, Krause E, Amann E, Limacher A, et al. Clinical scoring system for vulvar lichen sclerosus. J Sex Med. 2012;9(9):2342- 50
dc.source.bibliographicCitationPerez-Lopez FR, Vieira-Baptista P. Lichen sclerosus in women: a review. Climacteric. 2017;20(4):339-47.
dc.source.bibliographicCitationWallace HJ. Lichen sclerosus et atrophicus. Transactions of the St John's Hospital Dermatological Society. 1971;57(1):9-30
dc.source.bibliographicCitationFischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol. 1996;37(1):12-8
dc.source.bibliographicCitationStiles M, Redmer J, Paddock E, Schrager S. Gynecologic issues in geriatric women. Journal of women's health (2002). 2012;21(1):4-9.
dc.source.bibliographicCitationSullivan AK, Straughair GJ, Marwood RP, Staughton RC, Barton SE. A multidisciplinary vulva clinic: the role of genito-urinary medicine. J Eur Acad Dermatol Venereol. 1999;13(1):36-40.
dc.source.bibliographicCitationHiggins CA, Cruickshank ME. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus. J Obstet Gynaecol. 2012;32(3):271-5.
dc.source.bibliographicCitationGarcia-Llaver V PV, Flores F, Sánchez C, Tennerini L. Liquen escleroso vulvar y carcinoma espinocelular. Dermatol Argent. 2011;17(5):365-9
dc.source.bibliographicCitationHeller DS, Randolph P, Young A, Tancer ML, Fromer D. The cutaneous vulvar clinic revisited: a 5-year experience of the Columbia Presbyterian Medical Center Cutaneous- Vulvar Service. Dermatology. 1997;195(1):26-9
dc.source.bibliographicCitationGarcia-Bravo B, Sanchez-Pedreno P, Rodriguez-Pichardo A, Camacho F. Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes. J Am Acad Dermatol. 1988;19(3):482-5.
dc.source.bibliographicCitationSánchez-Largo E, Guerra-Tapia A. Caracterización clínica y epidemiológica del liquen escleroso. Act Dermatolog. 2006;4:249-54.
dc.source.bibliographicCitationNeill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002;147(4):640-9
dc.source.bibliographicCitationFischer G, Rogers M. Vulvar disease in children: a clinical audit of 130 cases. Pediatr Dermatol. 2000;17(1):1-6
dc.source.bibliographicCitationFischer GO. Vulval disease in pre-pubertal girls. Australas J Dermatol. 2001;42(4):225- 34; quiz, 35-6.
dc.source.bibliographicCitationFunaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther. 2004;17(1):28-37
dc.source.bibliographicCitationEdwards SK, Bates CM, Lewis F, Sethi G, Grover D. 2014 UK national guideline on the management of vulval conditions. Int J STD AIDS. 2015;26(9):611-24
dc.source.bibliographicCitationSherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24(9):1031-4.
dc.source.bibliographicCitationDendrinos ML, Quint EH. Lichen sclerosus in children and adolescents. Curr Opin Obstet Gynecol. 2013;25(5):370-4
dc.source.bibliographicCitationMonsálvez V, Rivera R, Vanaclocha F. Liquen escleroso. Actas Dermosifiliogr. 2010;101(1):31-8.
dc.source.bibliographicCitationGambichler T, Terras S, Kreuter A, Skrygan M. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus: further support for epigenetic mechanisms. Br J Dermatol. 2014;170(3):687-93.
dc.source.bibliographicCitationCooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008;144(11):1432-5
dc.source.bibliographicCitationBirenbaum DL, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med. 2007;52(1):28-30.
dc.source.bibliographicCitationEberz B, Berghold A, Regauer S. High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women. Obstet Gynecol. 2008;111(5):1143-7
dc.source.bibliographicCitationEdmonds EV, Oyama N, Chan I, Francis N, McGrath JA, Bunker CB. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol. 2011;165(1):218-9.
dc.source.bibliographicCitationLewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018;178(4):839-53
dc.source.bibliographicCitationPass CJ. An unusual variant of lichen sclerosus et atrophicus: delayed appearance in a surgical scar. Cutis. 1984;33(4):405, 8
dc.source.bibliographicCitationYates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol. 1985;121(8):1044-7
dc.source.bibliographicCitationBunker CB. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945- 56. Eur Urol. 2010;58(6):e55-6; author reply e7-8.
dc.source.bibliographicCitationEdmonds EV, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26(6):730-7.
dc.source.bibliographicCitationHaidopoulos D, Bakolas G, Michala L. Turner syndrome: don't forget the vulva. Endocrinol Diabetes Metab Case Rep. 2016;2016:160016.
dc.source.bibliographicCitationPotter JE, Moore KA. Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report. J Gen Intern Med. 2013;28(4):592-5
dc.source.bibliographicCitationVieira-Baptista P. Lichen sclerosus in breast cancer survivor. J Gen Intern Med. 2013;28(3):344
dc.source.bibliographicCitationFriedrich EG, Jr., Kalra PS. Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N Engl J Med. 1984;310(8):488- 91
dc.source.bibliographicCitationClifton MM, Garner IB, Kohler S, Smoller BR. Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol. 1999;41(1):43-6
dc.source.bibliographicCitationCarlson JA, Murphy M. Androgen receptors and lichen sclerosus. J Am Acad Dermatol. 2000;43(3):559-60.
dc.source.bibliographicCitationGunthert AR, Faber M, Knappe G, Hellriegel S, Emons G. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137(1):56-60.
dc.source.bibliographicCitationEisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol. 2008;144(5):591-8
dc.source.bibliographicCitationPowell J, Strauss S, Gray J, Wojnarowska F. Genital carriage of human papilloma virus (HPV) DNA in prepubertal girls with and without vulval disease. Pediatr Dermatol. 2003;20(3):191-4.
dc.source.bibliographicCitationBunker CB, Shim TN. Male genital lichen sclerosus. Indian J Dermatol. 2015;60(2):111-7.
dc.source.bibliographicCitationAide S, Lattario FR, Almeida G, do Val IC, da Costa Carvalho M. Epstein Barr virus and human papillomavirus infection in vulvar lichen sclerosus. J Low Genit Tract Dis. 2010;14(4):319-22.
dc.source.bibliographicCitationVieira-Baptista P, Lima-Silva J, Cavaco-Gomes J, Beires J, Martinez-de Oliveira J. What differentiates symptomatic from asymptomatic women with lichen sclerosus? Gynecol Obstet Invest. 2015;79(4):263-8.
dc.source.bibliographicCitationGuerra A. Liquen escleroso. Actas Dermosifiliogr. 2003;94(10):633-41
dc.source.bibliographicCitationPowell J, Wojnarowska F. Childhood vulval lichen sclerosus and sexual abuse are not mutually exclusive diagnoses. BMJ (Clinical research ed). 2000;320(7230):311.
dc.source.bibliographicCitationWarrington SA, de San Lazaro C. Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child. 1996;75(6):512-6.
dc.source.bibliographicCitationVan de Nieuwenhof HP, Meeuwis KA, Nieboer TE, Vergeer MC, Massuger LF, De Hullu JA. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol. 2010;31(4):279-84
dc.source.bibliographicCitationHaefner HK, Aldrich NZ, Dalton VK, Gagne HM, Marcus SB, Patel DA, et al. The impact of vulvar lichen sclerosus on sexual dysfunction. J Womens Health (Larchmt). 2014;23(9):765-70.
dc.source.bibliographicCitationVan Cranenburgh OD, Nijland SBW, Lindeboom R, de Korte J, de Rie MA, Ter Stege JA, et al. Patients with lichen sclerosus experience moderate satisfaction with treatment and impairment of quality of life: results of a cross sectional study. Br J Dermatol. 2017;176(6):1508-15.
dc.source.bibliographicCitationConde-Montero E. Abordaje psicológico en patología vulvar. Monogr Dermatol. 2015;28:180-3.
dc.source.bibliographicCitationGordon D, Gardella C, Eschenbach D, Mitchell CM. High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic. J Low Genit Tract Dis. 2016;20(1):80-4.
dc.source.bibliographicCitationVan de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68(2):131- 56.
dc.source.bibliographicCitationBradford J, Fischer G. Long-term management of vulval lichen sclerosus in adult women. Aust N Z J Obstet Gynaecol. 2010;50(2):148-52
dc.source.bibliographicCitationKirtschig G, Becker K, Günthert A, Jasaitiene D, Cooper S, Chi CC, et al. Evidence- based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29(10):e1-43.
dc.source.bibliographicCitationPerez-Lopez FR, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Rees M, et al. EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women. Maturitas. 2013;74(3):279-82
dc.source.bibliographicCitationLee A, Bradford J, Fischer G. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. JEADV. 2015; 29(10):e1-e43. J Eur Acad Dermatol Venereol. 2017;31(1):e57- e8
dc.source.bibliographicCitationDalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol. 1991;124(5):461-4.
dc.source.bibliographicCitationSelim MA, Hoang MP. A histologic review of vulvar inflammatory dermatoses and intraepithelial neoplasm. Dermatol Clin. 2010;28(4):649-67
dc.source.bibliographicCitationChi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011(12):CD008240.
dc.source.bibliographicCitationCorazza M, Borghi A, Minghetti S, Toni G, Virgili A. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial. J Eur Acad Dermatol Venereol. 2016;30(6):956-61.
dc.source.bibliographicCitationFischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med. 2007;52(4):329-31
dc.source.bibliographicCitationBorghi A, Minghetti S, Toni G, Virgili A, Corazza M. Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? J Dermatolog Treat. 2017:1-8.
dc.source.bibliographicCitationWolf B, Horn LC, Hockel M. Anogenital lichen sclerosus: Change of tissue position as pathogenetic factor. Gynecol Oncol Rep. 2017;20:73-4.
dc.source.bibliographicCitationAbramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv. 1996;51(3):193-9
dc.source.bibliographicCitationBrodrick B, Belkin ZR, Goldstein AT. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. Clin Dermatol. 2013;31(6):780-6.
dc.source.bibliographicCitationFlynn AN, King M, Rieff M, Krapf J, Goldstein AT. Patient Satisfaction of Surgical Treatment of Clitoral Phimosis and Labial Adhesions Caused by Lichen Sclerosus. Sex Med. 2015;3(4):251-5.
dc.source.bibliographicCitationBrauer M, van Lunsen RH, Laan ET, Burger MP. A Qualitative Study on Experiences After Vulvar Surgery in Women With Lichen Sclerosus and Sexual Pain. J Sex Med. 2016;13(7):1080-90.
dc.source.bibliographicCitationCooper SM, Arnold SJ. Vulvar lichen sclerosus. In: Ofori AO, editor. UpToDate. UpToDate, Waltham, MA. Consultado el 21 de Febrero de 2019
dc.source.bibliographicCitationDalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med. 1995;40(5):351-4
dc.source.bibliographicCitationOlejek A, Gabriel I, Bilska-Janosik A, Kozak-Darmas I, Kawczyk-Krupka A. ALA- Photodynamic treatment in Lichen sclerosus-clinical and immunological outcome focusing on the assesment of antinuclear antibodies. Photodiagnosis Photodyn Ther. 2017;18:128- 32
dc.source.bibliographicCitationBelotto RA, Chavantes MC, Tardivo JP, Euzebio Dos Santos R, Fernandes RCM, Horliana A, et al. Therapeutic comparison between treatments for Vulvar Lichen Sclerosus: study protocol of a randomized prospective and controlled trial. BMC Womens Health. 2017;17(1):61.
dc.source.bibliographicCitationBiniszkiewicz T, Olejek A, Kozak-Darmas I, Sieron A. Therapeutic effects of 5-ALA- induced photodynamic therapy in vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2005;2(2):157-60.
dc.source.bibliographicCitationSotiriou E, Apalla Z, Patsatsi A, Panagiotidou D. Recalcitrant vulvar lichen sclerosis treated with aminolevulinic acid-photodynamic therapy: a report of five cases. J Eur Acad Dermatol Venereol. 2008;22(11):1398-9
dc.source.bibliographicCitationImbernon-Moya A, Martinez-Perez M, Churruca-Grijelmo M, Lobato Berezo A, Vargas-Laguna E, Fernandez-Cogolludo E, et al. Photodynamic therapy as a therapeutic alternative in vulvar lichen sclerosus: series of 8 cases. Photodermatol Photoimmunol Photomed. 2016;32(5-6):307-10
dc.source.bibliographicCitationPeterson CM, Lane JE, Ratz JL. Successful carbon dioxide laser therapy for refractory anogenital lichen sclerosus. Dermatol Surg. 2004;30(8):1148-51
dc.source.bibliographicCitationLee A, Lim A, Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas J Dermatol. 2016;57(1):39-43
dc.source.bibliographicCitationHobson JG, Ibrahim SF, Mercurio MG. Recalcitrant Vulvar Lichen Sclerosus Treated With Erbium YAG Laser. JAMA Dermatol. 2019;155(2):254-6.
dc.source.bibliographicCitationEshtiaghi P, Sadownik LA. Fact or Fiction? Adipose-Derived Stem Cells and Platelet- Rich Plasma for the Treatment of Vulvar Lichen Sclerosus. J Low Genit Tract Dis. 2019;23(1):65-70.
dc.source.bibliographicCitationKroft, J., & Shier, M. (2012). A novel approach to the surgical management of clitoral phimosis. Journal of Obstetrics and Gynaecology Canada, 34(5), 465-471.
dc.source.bibliographicCitationFillmer, S., Müller, U., Urban, P., Poetke, M., Philipp, C. M., & Berlien, H. P. (2009). CO2 laser treatment of patients with anogenital lichen sclerosus–A retrospective study. Medical Laser Application, 24(4), 279- 284
dc.source.bibliographicCitationPeterson, C. M., Lane, J. E., & Ratz, J. L. (2004). Successful carbon dioxide laser therapy for refractory anogenital lichen sclerosus. Dermatologic surgery, 30(8), 1148-1151.
dc.source.bibliographicCitationLee, A., Lim, A., & Fischer, G. (2016). Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australasian Journal of Dermatology, 57(1), 39-43
dc.source.bibliographicCitationStewart k,et al. Fractional CO(2) laser treatment as adjuntive therapy to topical steroids for managing vulvar lichen sclerosus. Lasers Surg Med.2022;54:138-151
dc.source.bibliographicCitationBurkett LS, et al. Clobetasol compared with fractionated carbox dioxid laser for lichen sclerosus: a randomized controlled trial. Obstet Gynecol. 2021;137:968-978
dc.source.bibliographicCitationMitchell L,et al.Fractionated carbón dioxide laser for the treatmentof vulvar lichen sclerosus: a randomized controlled trial. Obstet Gynecol. 2021;137:979-987.
dc.source.bibliographicCitationPagano T,et al. Effect of rescue fractional microablative CO2 laser on symptons and sexual dysfunction in women affected by vulvar lichen sclerosus resistant to long-term use of topic corticosteroid: a prospective longitudinal study. Menopause.2020;27:418-422.
dc.source.bibliographicCitationMendieta-Eckert M,et al. Treatment of vulvar lichen sclerosus et atrophicus with fractional carbón dioxide laser therapy: a report of 4 cases. Actas Dermossifiliogr (Eng Ed). 2021;112:85-88.
dc.source.bibliographicCitationSalgado et al. Randomized clinical trial with fractional CO2 laser and Clobetasol in the treatment of vulvar lichen sclerosus: a clinic study of feasibility. BMC Research Notes.202316:33.
dc.source.bibliographicCitationGuo J-Q,et al. Clinical study on multi-focused laser in the treatment of vulvar lichen sclerosus. Front Surg 2022.9:919135. Doi:10.3389/fsurg.2022.919135
dc.source.bibliographicCitationMarzec A, et al. The use of CO2 laser in vulvar lichen sclerosus treatment-molecular evidence. Ginekol Pol. 2023. PMID: 37162144
dc.source.bibliographicCitationMoyal-Barracco M, Wendling J. Vulvar dermatosis. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):946-58.
dc.source.bibliographicCitationLee et al. (2015). Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA dermatology, 151 (10),1061-1067.
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subjectLiquen escleroso y atrófico
dc.subjectEnfermedades genitales
dc.subjectMorfea
dc.subjectNeoplasias de la vulva
dc.subjectCorticoesteroides
dc.subject.keywordLichen sclerosus et atrophicus
dc.subject.keywordGenital diseases
dc.subject.keywordMorphea
dc.subject.keywordVulvar neoplasms
dc.subject.keywordCorticosteroids
dc.titleEficacia del láser de Co2 en el tratamiento del liquen escleroso vulvar refractario
dc.title.TranslatedTitleEfficacy of CO₂ laser in the treatment of refractory vulvar lichen sclerosus
dc.typemasterThesis
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de grado
local.department.reportEscuela de Medicina y Ciencias de la Salud
local.regionesBogotá
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
Eficacia_del_laser_de_Co2_en_el_tratamiento_del_liquen_escleroso_vulvar_refractario.pdf
Tamaño:
1004.59 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Maestría en Epidemiología